Ionis Pharmaceuticals
Utility Patent Applications

Last updated:

List of all Ionis Pharmaceuticals patents 146 in total

Status Patent
Application
Utility: COMPOSITIONS AND METHODS FOR MODULATING TTR EXPRESSION External link
Filling date: 8 Sep 2025 Issue date: 1 Sep 2022
Application
Utility: MODULATORS OF HSD17B13 EXPRESSION External link
Filling date: 8 Sep 2025 Issue date: 1 Sep 2022
Application
Utility: SYNTHESIS OF OLIGOMERIC COMPOUNDS COMPRISING PHOSPHOROTHIOATE DIESTER AND PHOSPHODIESTER LINKAGES External link
Filling date: 8 Sep 2025 Issue date: 11 Aug 2022
Application
Utility: MODULATORS OF MALAT1 EXPRESSION External link
Filling date: 8 Sep 2025 Issue date: 4 Aug 2022
Application
Utility: MODULATORS OF IRF4 EXPRESSION External link
Filling date: 8 Sep 2025 Issue date: 4 Aug 2022
Application
Utility: COMPOSITIONS AND METHODS FOR MODULATING TAU EXPRESSION External link
Filling date: 8 Sep 2025 Issue date: 4 Aug 2022
Application
Utility: MODULATORS OF COMPLEMENT FACTOR B External link
Filling date: 8 Sep 2025 Issue date: 4 Aug 2022
Application
Utility: COMPOUNDS AND METHODS FOR REDUCING FUS EXPRESSION External link
Filling date: 8 Sep 2025 Issue date: 4 Aug 2022
Application
Utility: Compositions and Methods for Modulating MECP2 Expression External link
Filling date: 8 Sep 2025 Issue date: 21 Jul 2022
Application
Utility: MODULATION OF APOLIPOPROTEIN C-III (APOCIII) EXPRESSION IN LIPOPROTEIN LIPASE DEFICIENT (LPLD) POPULATIONS External link
Filling date: 8 Sep 2025 Issue date: 7 Jul 2022
Application
Utility: COMPOUNDS AND METHODS FOR REDUCING ATXN3 EXPRESSION External link
Filling date: 8 Sep 2025 Issue date: 23 Jun 2022
Application
Utility: LINKAGE MODIFIED OLIGOMERIC COMPOUNDS AND USES THEREOF External link
Filling date: 8 Sep 2025 Issue date: 16 Jun 2022
Application
Utility: COMPOSITIONS AND METHODS FOR ENHANCED INTESTINAL ABSORPTION OF CONJUGATED OLIGOMERIC COMPOUNDS External link
Filling date: 8 Sep 2025 Issue date: 16 Jun 2022
Application
Utility: MODULATION OF PREKALLIKREIN (PKK) EXPRESSION External link
Filling date: 8 Sep 2025 Issue date: 2 Jun 2022
Application
Utility: COMPOSITIONS COMPRISING ALTERNATING 2'-MODIFIED NUCLEOSIDES FOR USE IN GENE MODULATION External link
Filling date: 8 Sep 2025 Issue date: 26 May 2022
Application
Utility: METHODS FOR REDUCING ATAXIN-2 EXPRESSION External link
Filling date: 8 Sep 2025 Issue date: 26 May 2022
Application
Utility: COMPOUNDS AND METHODS FOR MODULATING ANGIOTENSINOGEN EXPRESSION External link
Filling date: 8 Sep 2025 Issue date: 19 May 2022
Application
Utility: METHODS OF TREATING BREAST CANCER External link
Filling date: 8 Sep 2025 Issue date: 12 May 2022
Application
Utility: COMPOUNDS AND METHODS FOR REDUCING PMP22 EXPRESSION External link
Filling date: 8 Sep 2025 Issue date: 14 Apr 2022
Application
Utility: COMPOSITIONS AND METHODS FOR TREATING AND PREVENTING AMYOTROPHIC LATERAL SCLEROSIS External link
Filling date: 8 Sep 2025 Issue date: 10 Mar 2022
Application
Utility: Compounds and Methods for Reducing ATXN2 Expression External link
Filling date: 8 Sep 2025 Issue date: 3 Mar 2022
Application
Utility: COMPOUNDS AND METHODS FOR MODULATING SMN2 External link
Filling date: 8 Sep 2025 Issue date: 3 Mar 2022
Application
Utility: MODIFIED OLIGOMERIC COMPOUNDS AND USES THEREOF External link
Filling date: 8 Sep 2025 Issue date: 3 Mar 2022
Application
Utility: MODULATORS OF IRF5 EXPRESSION External link
Filling date: 8 Sep 2025 Issue date: 17 Feb 2022
Application
Utility: COMPOSITIONS AND METHODS FOR MODULATING APOLIPOPROTEIN C-III EXPRESSION External link
Filling date: 8 Sep 2025 Issue date: 23 Dec 2021
Application
Utility: CHIRALLY ENRICHED OLIGOMERIC COMPOUNDS External link
Filling date: 8 Sep 2025 Issue date: 9 Dec 2021
Application
Utility: OLIGONUCLEOTIDE MEDIATED NO-GO DECAY External link
Filling date: 8 Sep 2025 Issue date: 18 Nov 2021
Application
Utility: COMPOUNDS AND METHODS FOR REDUCING FXI EXPRESSION External link
Filling date: 8 Sep 2025 Issue date: 18 Nov 2021
Application
Utility: ALLELE SPECIFIC MODULATORS OF P23H RHODOPSIN External link
Filling date: 8 Sep 2025 Issue date: 11 Nov 2021
Application
Utility: GLP-1 Receptor Ligand Moiety Conjugated Oligonucleotides and Uses Thereof External link
Filling date: 8 Sep 2025 Issue date: 11 Nov 2021
Application
Utility: METHODS FOR REDUCING LRRK2 EXPRESSION External link
Filling date: 8 Sep 2025 Issue date: 4 Nov 2021
Application
Utility: Compounds and Methods for Modulation of Transcript Processing External link
Filling date: 8 Sep 2025 Issue date: 14 Oct 2021
Application
Utility: Compounds and Methods for the Modulation of Proteins External link
Filling date: 8 Sep 2025 Issue date: 2 Sep 2021
Application
Utility: Selective Antisense Compounds and Uses Thereof External link
Filling date: 8 Sep 2025 Issue date: 5 Aug 2021
Application
Utility: COMPOSITIONS FOR MODULATING EXPRESSION OF C9ORF72 ANTISENSE TRANSCRIPT External link
Filling date: 8 Sep 2025 Issue date: 15 Jul 2021
Application
Utility: COMPOSITIONS AND METHODS FOR MODULATING GROWTH HORMONE RECEPTOR EXPRESSION External link
Filling date: 8 Sep 2025 Issue date: 8 Jul 2021
Application
Utility: MODULATORS OF ENaC EXPRESSION External link
Filling date: 8 Sep 2025 Issue date: 17 Jun 2021
Application
Utility: MODULATION OF FACTOR 11 EXPRESSION External link
Filling date: 8 Sep 2025 Issue date: 10 Jun 2021
Application
Utility: Conjugated Antisense Compounds for Use in Therapy External link
Filling date: 8 Sep 2025 Issue date: 10 Jun 2021
Application
Utility: METHODS FOR REDUCING C9ORF72 EXPRESSION External link
Filling date: 8 Sep 2025 Issue date: 10 Jun 2021
Application
Utility: METHODS OF MODULATING ANTISENSE ACTIVITY External link
Filling date: 8 Sep 2025 Issue date: 10 Jun 2021
Application
Utility: MODULATORS OF EZH2 EXPRESSION External link
Filling date: 8 Sep 2025 Issue date: 27 May 2021
Application
Utility: Selective Antisense Compounds and Uses Thereof External link
Filling date: 8 Sep 2025 Issue date: 20 May 2021
Application
Utility: Oligomeric Compounds Comprising Bicyclic Nucleotides and Uses Thereof External link
Filling date: 8 Sep 2025 Issue date: 20 May 2021
Application
Utility: COMPOUNDS AND METHODS FOR REDUCING SPDEF EXPRESSION External link
Filling date: 8 Sep 2025 Issue date: 13 May 2021
Application
Utility: MODULATION OF HUNTINGTIN EXPRESSION External link
Filling date: 8 Sep 2025 Issue date: 13 May 2021
Application
Utility: COMPOSITIONS AND METHODS External link
Filling date: 8 Sep 2025 Issue date: 6 May 2021
Application
Utility: METHODS OF MODULATING ANTISENSE ACTIVITY External link
Filling date: 8 Sep 2025 Issue date: 6 May 2021
Application
Utility: MODULATORS OF YAP1 EXPRESSION External link
Filling date: 8 Sep 2025 Issue date: 29 Apr 2021
Application
Utility: MODULATION OF TRANSTHYRETIN EXPRESSION External link
Filling date: 8 Sep 2025 Issue date: 1 Apr 2021

Showing 1 to 50 of 146 patents.